Abstract: Aspects of the present disclosure involve a system and method for journaling transactions and identifying and correcting transaction errors. In one embodiment, a system is introduced that includes isolated clusters that are capable of journaling the state of a transaction after every critical step. In another embodiment, the system is introduced that can sweep the journaled transactions in order to identify post-processing transactional errors. Still in another embodiment, a system is introduced that is capable of performing a self-correcting mechanism that enables error correction in the background without presenting a failed notification to a customer.

Abstract: The systems and methods that warm-up a virtual machine are provided. An application byte code is generated from an application source code for an application that processes time-sensitive messages using a virtual machine. The virtual machine is configured to interpret the application byte code. A warm-up data is received by the virtual machine. The warm-up data is configured to emulate one or more time-sensitive messages processed by the virtual machine. From the warm-up data, the virtual machine generates application machine-readable code from the application byte code, and stores the application machine-readable code. After the virtual machine generates the application machine-readable code, a computing device that includes the virtual machine is placed in a real-world environment and begins to receive the time-sensitive messages. The virtual machine processes the time-sensitive messages using the generated application machine-readable code.

Abstract: The systems and methods that warm-up a virtual machine are provided. An application byte code is generated from an application source code for an application that processes time-sensitive messages using a virtual machine. The virtual machine is configured to interpret the application byte code. A warm-up data is received by the virtual machine. The warm-up data is configured to emulate one or more time-sensitive messages processed by the virtual machine. From the warm-up data, the virtual machine generates application machine-readable code from the application byte code, and stores the application machine-readable code. After the virtual machine generates the application machine-readable code, a computing device that includes the virtual machine is placed in a real-world environment and begins to receive the time-sensitive messages. The virtual machine processes the time-sensitive messages using the generated application machine-readable code.

Abstract: The present disclosure provides a method of inhibiting angiogenesis within a tissue of interest by providing either intact or nicked ?2-Glycoprotein 1 (?GP1) to cells associated with the tissue. The presence of ?2GP1 inhibits angiogenesis within the tissue, in part by preventing neovascularization into the tissue. The disclosure also provides a method for treating tumors by providing ?2GP1 to the tumor.

Abstract: The present disclosure provides a method of inhibiting angiogenesis within a tissue of interest by providing either intact or nicked ?-Glycoprotein 1 (?2GP1) to cells associated with the tissue. The presence of ?2GP1 inhibits angiogenesis within the tissue, in part by preventing neovascularization into the tissue. The disclosure also provides a method for treating tumors by providing ?2GP1 to the tumor.

Abstract: The present disclosure provides a method of inhibiting angiogenesis within a tissue of interest by providing either intact or nicked ?-Glycoprotein 1 (?2GP1) to cells associated with the tissue. The presence of ?2GP1 inhibits angiogenesis within the tissue, in part by preventing neovascularization into the tissue. The disclosure also provides a method for treating tumors by providing ?2GP1 to the tumor.

Abstract: The present disclosure provides a method of inhibiting angiogenesis within a tissue of interest by providing either intact or nicked ?2-Glycoprotein 1 (?2GP1) to cells associated with the tissue. The presence of ?2GP1 inhibits angiogenesis within the tissue, in part by preventing neovascularization into the tissue. The disclosure also provides a method for treating tumors by providing ?2GP1 to the tumor.

Abstract: The present disclosure provides a method of inhibiting angiogenesis within a tissue of interest by providing either intact or nicked &bgr;2-Glycoprotein 1 (&bgr;2GP1) to cells associated with the tissue. The presence of &bgr;2GP1 inhibits angiogenesis within the tissue, in part by preventing neovascularization into the tissue. The disclosure also provides a method for treating tumors by providing &bgr;2GP1 to the tumor.